ISSAR Pharma


With over 2,000,000 scientist hours into new peptide drug development, ISSAR has touched 1,00,000 plus lives meeting our mission of delivering affordable, novel peptide drugs for the unmet healthcare needs.

Comparative Study Of Efficacy and Safety of Topical Active Fragment of Basic
Fibroblast Growth Factor (B FGF) 0.1% Solution V/S Betamethasone Valerate 0.1%
Ointment in the Treatment of Vitiligo Patients
“GENOPEP”, a Topical Cream in the Treatment
of Burn Wounds